Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (381-390 of 443) with videos related to

Pageof 45
Sort By:
Cancer|October 29, 2020
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Rose-Marie Hamladji, et al.
American Journal of Hematology|April 7, 2025
Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Fit Patients With Acute Myeloid Leukemia Transplanted in First Remission: A Study From the Global Committee and the Acute Leukemia Working Party of the EBMTYishan Ye, Allain Thibeault Ferhat Berland, Myriam Labopin, et al.
Blood Advances|March 1, 2024
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMTJaime Sanz, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|April 7, 2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019Rafael F Duarte, Myriam Labopin, Peter Bader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation StudySalyka Sengsayadeth, Myriam Labopin, Ariane Boumendil, et al.
Hemasphere|October 19, 2022
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete RemissionMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Bone Marrow Transplantation|February 1, 2023
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Transplantation and Cellular Therapy|August 16, 2025
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT RegistrySandra Cohen, Myriam Labopin, Nadia Bambace, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Journal of Hematology & Oncology|June 26, 2017
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Matthias Stelljes, et al.
Pageof 45

Showing results (381-390 of 443) with videos related to

Sort By:
Pageof 45
Cancer|October 29, 2020
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Rose-Marie Hamladji, et al.
American Journal of Hematology|April 7, 2025
Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Fit Patients With Acute Myeloid Leukemia Transplanted in First Remission: A Study From the Global Committee and the Acute Leukemia Working Party of the EBMTYishan Ye, Allain Thibeault Ferhat Berland, Myriam Labopin, et al.
Blood Advances|March 1, 2024
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMTJaime Sanz, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|April 7, 2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019Rafael F Duarte, Myriam Labopin, Peter Bader, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation StudySalyka Sengsayadeth, Myriam Labopin, Ariane Boumendil, et al.
Hemasphere|October 19, 2022
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete RemissionMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Bone Marrow Transplantation|February 1, 2023
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Transplantation and Cellular Therapy|August 16, 2025
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT RegistrySandra Cohen, Myriam Labopin, Nadia Bambace, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Journal of Hematology & Oncology|June 26, 2017
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Matthias Stelljes, et al.
Pageof 45